Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Revlimid
Related studies linked through entity extraction aliases.
R2 in the Treatment of Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
- Status
- COMPLETED
- Phase
- N/A
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan
- Status
- COMPLETED
- Phase
- N/A
Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL
- Status
- TERMINATED
- Phase
- PHASE2
Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
- Status
- COMPLETED
- Phase
- PHASE2
Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2